Liminatus Pharma, Inc. Class A Common Stock Tangible Net Worth Ratio
Liminatus Pharma, Inc. Class A Common Stock tangible net worth ratio. Liminatus Pharma, Inc. Class A Common Stock (LIMN) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($300.61K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Liminatus Pharma, Inc. Class A Common St balance sheet quality to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Liminatus Pharma, Inc. Class A Common Stock (2021–2022)
Tangible net worth ratio of Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2022. This chart shows how Liminatus Pharma, Inc. Class A Common Stock's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2022. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $300.61K with intangible assets of $0.00 USD. See working capital position of Liminatus Pharma, Inc. Class A Common St to evaluate short-term liquidity relative to the company's equity base.
Liminatus Pharma, Inc. Class A Common Stock Tangible Net Worth Ratio by Year (2021–2022)
Liminatus Pharma, Inc. Class A Common Stock tangible net worth ratio by year from 2021 to 2022. The table below presents the year-by-year Tangible Net Worth Ratio for Liminatus Pharma, Inc. Class A Common Stock from 2021 to 2022, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Liminatus Pharma, Inc. Class A Common St market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2022 | 100.0% | $1.29 Million | $0.00 | $15.49 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $254.87 Million | $0.00 | $276.44 Million | — |